- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Acalabrutinib, as a BTK inhibitor, should be scheduled according to the indications and individual patient conditions. It is usually administer...
Acalabrutinib, as a BTK inhibitor, should be used with a focus on bleeding risk, infection prevention and control, and medication safety for sp...
The relationship between the administration time and diet of Acalabrutinib needs to be comprehensively considered based on the characteristics ...
Acalabrutinib, as a BTK inhibitor, has a different onset time due to individual differences and disease types. It usually requires continuous ...
The daily dosage of Selinexor should be calculated based on the dosage form specifications and prescription dosage, and the specific dosage sho...
Selinexor, as a novel nuclear export inhibitor, is mainly effective in the treatment of recurrent/refractory hematological tumors, demonstratin...
Valcyte is an antiviral drug mainly used to treat cytomegalovirus infection and related diseases, with the effects of inhibiting virus replicat...
Valcyte is an antiviral drug primarily used for the treatment and prevention of cytomegalovirus infection, particularly suitable for immunocomp...
Ruxolitinib is a JAK1/JAK2 kinase inhibitor mainly used to treat myeloproliferative tumors such as myelofibrosis and polycythemia vera, as well...
Mobocetinib is an oral EGFR tyrosine kinase inhibitor specifically targeting EGFR exon 20 insertion mutations, used to treat non-small cell lun...
